CRISPR & Cas Genes Market

Global CRISPR & Cas Genes Market by Products (Vector-based Cas and DNA-free Cas), Applications (Genome Engineering, Disease Models, Functional Genomics, and Others), End-users (Biotechnology & Pharmaceutical Companies, Academics & Government Research Institutes, and Contract Research Organizations), and Regions (Asia Pacific, North America, Europe, Latin America, and Middle East & Africa) - Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

  • Report ID: HC-3107
  • Author: Growth Market Reports
  • Rating: 4.8
  • Total Reviews: 40
  • No. Of Pages: 185
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global CRISPR & cas genes market size was valued at USD 1,563.52 million in 2020 and is expected to surpass USD 3,733.66 million by 2026, expanding at a CAGR of 15.67% during the forecast period, 2021–2028. The growth of the market is attributed to its increased use in several domains of biotechnology, such as epigenetics and medicine, human germline editing, and a tool for qualitative and quantitative plant genome editing.

CRISPR & Cas Genes Market key takeaways

CRISPR-cas techniques are powerful nucleic acid-targeting technologies that are simple to program. Its applications span from research and drug discovery to precision breeding of plants and animals and industrial microbial engineering. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) is a gene editing method. CRISPR-cas is a significant breakthrough in biological science. It offers the potential to cure rare diseases in a variety of contexts. Researchers use this technology to change elements of the genome by adding, changing, or removing sections of the DNA sequence. Many patients undergoing CRISPR-Cas gene therapy are being monitored and are waiting for FDA approval.

The CRISPR-Cas system is a prokaryotic immune system that enables acquired immunity by conferring resistance to exogenous genetic elements. It is faster, more efficient, and more precise than previous DNA modification techniques, and it has a wide range of possible uses. Crop breeding, biotechnology and pharmaceutical businesses, microbial engineering, and genome engineering all use this method.

Market Trends, Drivers, Restraints, and Opportunities:

Drivers

  • Increasing number of strategic collaborations between market players is projected to boost the market during the forecast period.
  • Rising funding and investments in gene editing technologies is expected to promote the growth of the market during the forecast period.
  • Development of CRISPR technologies is anticipated to boost the market.
  • Increasing incidence of genetic disorders is expected to fuel the market during the forecast period.

Restraints

  • Rising ethical and safety issues regarding CRISPR technologies is expected to hinder the market growth during the forecast period.
  • Availability of alternatives of CRISPR & cas genes is anticipated to hamper the market expansion in the coming years.

Opportunities

  • Increasing number of clinical trials using CRISPR technology to develop treatments for diseases such as thalassemia, sickle cell disease, myeloma, solid tumors, and hematologic malignancies, diabetes, and others, is expected to create opportunities for the market players.

 

Scope of the Report

The report on the global CRISPR & cas genes market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

CRISPR & Cas Genes Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Products (Vector-based Cas and DNA-free Cas), Applications (Genome Engineering, Disease Models, Functional Genomics, and Others), End-users (Biotechnology & Pharmaceutical Companies, Academics & Government Research Institutes, and Contract Research Organizations)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

OriGene Technologies, Inc., Thermo Fisher Scientific, Takara Bio Inc, Horizon Discovery Ltd., Addgene, Merck KGaA, Caribou Biosciences, Inc., CRISPR THERAPEUTICS, Editas Medicine, and Mirus Bio LLC

 

Global CRISPR & Cas Genes Market Segment Insights

Vector-based Cas to drive the market

Based on products, the CRISPR & cas genes market is divided into vector-based cas and DNA-free cas. The vector-based cas segment is anticipated to dominate the market during the forecast period. Medical researchers focusing on Cas9 enrichment benefit from vector-based cas systems. A promoter is usually included in the vector-based cas, allowing stable cell lines to be created.

CRISPR & Cas Genes Market by products

Genome engineering to drive the market

In terms of applications, the global CRISPR & cas genes market is segregated into genome engineering, disease models, functional genomics, and others. The genome engineering segment is anticipated to dominate the market during the forecast period. To generate genomic engineering, natural genomic sequences are coupled with a synthetic assembly of entire chromosomal DNA. The method allows for the addition, modification, or removal of genetic material from specified genomic sites. For the foreseeable future, extensive biomedical research is expected to propel the market.

CRISPR & Cas Genes Market by applications

Rising adoption of CRISPR technology by biotechnology and pharmaceutical companies to drive the market

On the basis of end users, the global CRISPR & cas genes market is segregated into biotechnology & pharmaceutical companies, academics & government research institutes, and contract research organizations. The biotechnology and pharmaceutical companies segment is anticipated to dominate the market during the forecast period. The segment is being fueled by the rising adoption of CRISPR technology by prominent biotechnology and pharmaceutical companies. Companies are increasingly turning to CRISPR-Cas9 to generate biological models for human diseases in less time and to speed up the discovery and validation of new therapeutic targets.

North America to dominate the market

On the basis of regions, the global CRISPR & cas genes market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to dominate the market at a high CAGR during the forecast period. Factors such as the existence of significant companies, increased spending in biotechnology and genomics programs, and developed healthcare infrastructure are some of the primary factors responsible for the large share of the market in North America.

Segments

By Products

  • Vector-based Cas
  • DNA-free Cas

By Applications

  • Genome Engineering
  • Disease Models
  • Functional Genomics
  • Others

By End-users

  • Biotechnology & Pharmaceutical Companies
  • Academics & Government Research Institutes
  • Contract Research Organizations

By Regions

  • Asia Pacific
  • North America
  • Europe, Latin America
  • Middle East & Africa

By Key Players

  • OriGene Technologies, Inc.
  • Thermo Fisher Scientific
  • Takara Bio Inc
  • Horizon Discovery Ltd.
  • Addgene
  • Merck KGaA
  • Caribou Biosciences, Inc.
  • CRISPR THERAPEUTICS
  • Editas Medicine
  • Mirus Bio LLC

Competitive Landscape

The global CRISPR and CRISPR-associated (Cas) genes market is relatively consolidated, with only a few prominent competitors. OriGene Technologies, Inc., Thermo Fisher Scientific, Takara Bio Inc, Horizon Discovery Ltd., Addgene, Merck KGaA, Caribou Biosciences, Inc., CRISPR THERAPEUTICS, Editas Medicine, and Mirus Bio LLC are some of the key companies in the market.

CRISPR & Cas Genes Market by key players

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. CRISPR & Cas Genes Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. CRISPR & Cas Genes Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. CRISPR & Cas Genes Market - Supply Chain
  4.5. Global CRISPR & Cas Genes Market Forecast
     4.5.1. CRISPR & Cas Genes Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. CRISPR & Cas Genes Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. CRISPR & Cas Genes Market Absolute $ Opportunity
5. Global CRISPR & Cas Genes Market Analysis and Forecast by Applications
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Applications
     5.2.2. Y-o-Y Growth Projections by Applications
  5.3. CRISPR & Cas Genes Market Size and Volume Forecast by Applications
     5.3.1. Genome Engineering
     5.3.2. Disease Models
     5.3.3. Functional Genomics
     5.3.4. Others
  5.4. Absolute $ Opportunity Assessment by Applications
  5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global CRISPR & Cas Genes Market Analysis and Forecast by End Users
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by End Users
     6.2.2. Y-o-Y Growth Projections by End Users
  6.3. CRISPR & Cas Genes Market Size and Volume Forecast by End Users
     6.3.1. Biotechnology & Pharmaceutical Companies
     6.3.2. Academics & Government Research Institutes
     6.3.3. Contract Research Organizations
  6.4. Absolute $ Opportunity Assessment by End Users
  6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global CRISPR & Cas Genes Market Analysis and Forecast by Region
  7.1. Market Trends
  7.2. Introduction
     7.2.1. Basis Point Share (BPS) Analysis by Region
     7.2.2. Y-o-Y Growth Projections by Region
  7.3. CRISPR & Cas Genes Market Size and Volume Forecast by Region
     7.3.1. North America
     7.3.2. Latin America
     7.3.3. Europe
     7.3.4. Asia Pacific
     7.3.5. Middle East and Africa (MEA)
  7.4. Absolute $ Opportunity Assessment by Region
  7.5. Market Attractiveness/Growth Potential Analysis by Region
  7.6. Global CRISPR & Cas Genes Demand Share Forecast, 2019-2026
8. North America CRISPR & Cas Genes Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
  8.2. North America CRISPR & Cas Genes Market Size and Volume Forecast by Country
     8.2.1. U.S.
     8.2.2. Canada
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. North America CRISPR & Cas Genes Market Size and Volume Forecast by Applications
     8.4.1. Genome Engineering
     8.4.2. Disease Models
     8.4.3. Functional Genomics
     8.4.4. Others
  8.5. Basis Point Share (BPS) Analysis by Applications
  8.6. Y-o-Y Growth Projections by Applications
  8.7. North America CRISPR & Cas Genes Market Size and Volume Forecast by End Users
     8.7.1. Biotechnology & Pharmaceutical Companies
     8.7.2. Academics & Government Research Institutes
     8.7.3. Contract Research Organizations
  8.8. Basis Point Share (BPS) Analysis by End Users
  8.9. Y-o-Y Growth Projections by End Users
  8.10. Market Attractiveness/Growth Potential Analysis
     8.10.1. By Country
     8.10.2. By Product Type
     8.10.3. By Application
  8.11. North America CRISPR & Cas Genes Demand Share Forecast, 2019-2026
9. Latin America CRISPR & Cas Genes Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Latin America Average Pricing Analysis
  9.2. Latin America CRISPR & Cas Genes Market Size and Volume Forecast by Country
      9.2.1. Brazil
      9.2.2. Mexico
      9.2.3. Rest of Latin America
   9.3. Absolute $ Opportunity Assessment by Country
  9.4. Latin America CRISPR & Cas Genes Market Size and Volume Forecast by Applications
     9.4.1. Genome Engineering
     9.4.2. Disease Models
     9.4.3. Functional Genomics
     9.4.4. Others
  9.5. Basis Point Share (BPS) Analysis by Applications
  9.6. Y-o-Y Growth Projections by Applications
  9.7. Latin America CRISPR & Cas Genes Market Size and Volume Forecast by End Users
     9.7.1. Biotechnology & Pharmaceutical Companies
     9.7.2. Academics & Government Research Institutes
     9.7.3. Contract Research Organizations
  9.8. Basis Point Share (BPS) Analysis by End Users
  9.9. Y-o-Y Growth Projections by End Users
  9.10. Market Attractiveness/Growth Potential Analysis
     9.10.1. By Country
     9.10.2. By Product Type
     9.10.3. By Application
  9.11. Latin America CRISPR & Cas Genes Demand Share Forecast, 2019-2026
10. Europe CRISPR & Cas Genes Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Europe Average Pricing Analysis
  10.2. Europe CRISPR & Cas Genes Market Size and Volume Forecast by Country
     10.2.1. Germany
     10.2.2. France
     10.2.3. Italy
     10.2.4. U.K.
     10.2.5. Spain
     10.2.6. Russia
     10.2.7. Rest of Europe
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Europe CRISPR & Cas Genes Market Size and Volume Forecast by Applications
     10.4.1. Genome Engineering
     10.4.2. Disease Models
     10.4.3. Functional Genomics
     10.4.4. Others
  10.5. Basis Point Share (BPS) Analysis by Applications
  10.6. Y-o-Y Growth Projections by Applications
  10.7. Europe CRISPR & Cas Genes Market Size and Volume Forecast by End Users
     10.7.1. Biotechnology & Pharmaceutical Companies
     10.7.2. Academics & Government Research Institutes
     10.7.3. Contract Research Organizations
  10.8. Basis Point Share (BPS) Analysis by End Users
  10.9. Y-o-Y Growth Projections by End Users
  10.10. Market Attractiveness/Growth Potential Analysis
     10.10.1. By Country
     10.10.2. By Product Type
     10.10.3. By Application
  10.11. Europe CRISPR & Cas Genes Demand Share Forecast, 2019-2026
11. Asia Pacific CRISPR & Cas Genes Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Asia Pacific Average Pricing Analysis
  11.2. Asia Pacific CRISPR & Cas Genes Market Size and Volume Forecast by Country
     11.2.1. China
     11.2.2. Japan
     11.2.3. South Korea
     11.2.4. India
     11.2.5. Australia
     11.2.6. Rest of Asia Pacific (APAC)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Asia Pacific CRISPR & Cas Genes Market Size and Volume Forecast by Applications
     11.4.1. Genome Engineering
     11.4.2. Disease Models
     11.4.3. Functional Genomics
     11.4.4. Others
  11.5. Basis Point Share (BPS) Analysis by Applications
  11.6. Y-o-Y Growth Projections by Applications
  11.7. Asia Pacific CRISPR & Cas Genes Market Size and Volume Forecast by End Users
     11.7.1. Biotechnology & Pharmaceutical Companies
     11.7.2. Academics & Government Research Institutes
     11.7.3. Contract Research Organizations
  11.8. Basis Point Share (BPS) Analysis by End Users
  11.9. Y-o-Y Growth Projections by End Users
  11.10. Market Attractiveness/Growth Potential Analysis
     11.10.1. By Country
     11.10.2. By Product Type
     11.10.3. By Application
  11.11. Asia Pacific CRISPR & Cas Genes Demand Share Forecast, 2019-2026
12. Middle East & Africa CRISPR & Cas Genes Market Analysis and Forecast
  12.1. Introduction
     12.1.1. Basis Point Share (BPS) Analysis by Country
     12.1.2. Y-o-Y Growth Projections by Country
     12.1.3. Middle East & Africa Average Pricing Analysis
  12.2. Middle East & Africa CRISPR & Cas Genes Market Size and Volume Forecast by Country
     12.2.1. Saudi Arabia
     12.2.2. South Africa
     12.2.3. UAE
     12.2.4. Rest of Middle East & Africa (MEA)
  12.3. Absolute $ Opportunity Assessment by Country
  12.4. Middle East & Africa CRISPR & Cas Genes Market Size and Volume Forecast by Applications
     12.4.1. Genome Engineering
     12.4.2. Disease Models
     12.4.3. Functional Genomics
     12.4.4. Others
  12.5. Basis Point Share (BPS) Analysis by Applications
  12.6. Y-o-Y Growth Projections by Applications
  12.7. Middle East & Africa CRISPR & Cas Genes Market Size and Volume Forecast by End Users
     12.7.1. Biotechnology & Pharmaceutical Companies
     12.7.2. Academics & Government Research Institutes
     12.7.3. Contract Research Organizations
  12.8. Basis Point Share (BPS) Analysis by End Users
  12.9. Y-o-Y Growth Projections by End Users
  12.10. Market Attractiveness/Growth Potential Analysis
     12.10.1. By Country
     12.10.2. By Product Type
     12.10.3. By Application
  12.11. Middle East & Africa CRISPR & Cas Genes Demand Share Forecast, 2019-2026
13. Competition Landscape
  13.1. Global CRISPR & Cas Genes Market: Market Share Analysis
  13.2. CRISPR & Cas Genes Distributors and Customers
  13.3. CRISPR & Cas Genes Market: Competitive Dashboard
  13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     13.4.1. OriGene Technologies, Inc.
     13.4.2. Thermo Fisher Scientific
     13.4.3. Takara Bio Inc
     13.4.4. Horizon Discovery Ltd.
     13.4.5. Addgene
     13.4.6. Merck KGaA
     13.4.7. Caribou Biosciences, Inc.

By Products

  • Vector-based Cas
  • DNA-free Cas

By Applications

  • Genome Engineering
  • Disease Models
  • Functional Genomics
  • Others

By End-users

  • Biotechnology & Pharmaceutical Companies
  • Academics & Government Research Institutes
  • Contract Research Organizations

By Regions

  • Asia Pacific
  • North America
  • Europe, Latin America
  • Middle East & Africa

By Key Players

  • OriGene Technologies, Inc.
  • Thermo Fisher Scientific
  • Takara Bio Inc
  • Horizon Discovery Ltd.
  • Addgene
  • Merck KGaA
  • Caribou Biosciences, Inc.
  • CRISPR THERAPEUTICS
  • Editas Medicine
  • Mirus Bio LLC

The global CRISPR and CRISPR-associated (Cas) genes market is relatively consolidated, with only a few prominent competitors. OriGene Technologies, Inc., Thermo Fisher Scientific, Takara Bio Inc, Horizon Discovery Ltd., Addgene, Merck KGaA, Caribou Biosciences, Inc., CRISPR THERAPEUTICS, Editas Medicine, and Mirus Bio LLC are some of the key companies in the market.

CRISPR & Cas Genes Market by key players

Buy Report